D1- and D2-like receptors differentially mediate the effects of dopaminergic transmission on cost-benefit evaluation and motivation in monkeys

PLoS Biol. 2021 Jul 1;19(7):e3001055. doi: 10.1371/journal.pbio.3001055. eCollection 2021 Jul.

Abstract

It has been widely accepted that dopamine (DA) plays a major role in motivation, yet the specific contribution of DA signaling at D1-like receptor (D1R) and D2-like receptor (D2R) to cost-benefit trade-off remains unclear. Here, by combining pharmacological manipulation of DA receptors (DARs) and positron emission tomography (PET) imaging, we assessed the relationship between the degree of D1R/D2R blockade and changes in benefit- and cost-based motivation for goal-directed behavior of macaque monkeys. We found that the degree of blockade of either D1R or D2R was associated with a reduction of the positive impact of reward amount and increasing delay discounting. Workload discounting was selectively increased by D2R antagonism. In addition, blocking both D1R and D2R had a synergistic effect on delay discounting but an antagonist effect on workload discounting. These results provide fundamental insight into the distinct mechanisms of DA action in the regulation of the benefit- and cost-based motivation, which have important implications for motivational alterations in both neurological and psychiatric disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cost-Benefit Analysis*
  • Delay Discounting
  • Dopamine / metabolism*
  • Dopamine Antagonists / pharmacology
  • Macaca fuscata
  • Macaca mulatta / physiology*
  • Male
  • Motivation*
  • Positron-Emission Tomography
  • Receptors, Dopamine D1 / drug effects
  • Receptors, Dopamine D1 / physiology*
  • Receptors, Dopamine D2 / drug effects
  • Receptors, Dopamine D2 / physiology*
  • Workload

Substances

  • Dopamine Antagonists
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Dopamine

Grants and funding

This research was supported in part by KAKENHI Grants JP26282221, JP26120733, JP18H04037, and JP20H05955 from Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html) to TM, and by Japan Agency for Medical Research and Development (AMED) (https://www.amed.go.jp/en/index.html) Grant Numbers JP20dm0107094 (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.